Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Metastatic Urothelial Cancer

Urothelial Bladder Carcinoma

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Transitional Cell, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Bile Duct Neoplasms, Cholangiocarcinoma

Carcinoma, Neuroendocrine

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Liposarcoma, Sarcoma

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

Advanced Non-Small Cell Lung Cancer

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

Oligometastatic Prostate Cancer

Neoplasms, Prostatic Neoplasms

Clinical Trials

VELOCITY-Lung

TROPHY U-01

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

ARC-10

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

VELOCITY-HNSCC

EDGE-Gastric

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

REWENEC 01

Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma

ELEVATE HNSCC

Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

IMMUNORARE5

EDGE-Lung

PANTHER

ARC-7

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Domvanalimab and Zimberelimab in Advanced Liver Cancers

SBRT-AMICO

Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer

Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma